Panelists discuss how identifying type 2 inflammation in patients influences treatment decisions by steering clinicians toward targeted therapies, such as biologics or other immunomodulators, that ...
(BPT) – Do you live with persistent, moderate-to-severe asthma, COPD, allergies, eczema or hives? Inflammation is often a major factor in the severity of your symptoms. It could also be a factor if ...
Panelists discuss how biomarkers of type 2 inflammation, such as blood eosinophils, serum IgE, and fractional exhaled nitric oxide, can aid in diagnosing and monitoring type 2 inflammatory diseases as ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Patients receiving mepolizumab vs. placebo had a smaller ...
Two weeks of an intensive diabetes treatment has shown promise in improving periodontal disease inflammation among patients with type 2 diabetes. The corresponding study was published in Diabetes, ...
An experimental drug once known for helping control type 2 diabetes may also fight heart disease. Researchers found IC7Fc ...
An international research team has uncovered a surprising ally in the fight against insulin resistance and type 2 diabetes: a microbial metabolite called trimethylamine (TMA). Published in Nature ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results